In human lung cancers, GATA6 is rarely mutated, but its expression is increased in early stage non small cell lung cancer (NSCLC) relative to normal tissue and may correlate with tumor promoting genes [10, 11]. This evidence concerns the gene GATA6 and non-small cell lung carcinoma.